fashion -WSS

fashion

author：explore 2025-09-30 12:10:22 - browse：261

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of expert advisers to the Food and Drug Administration on Friday voted in favor of expanding the use of CAR-T therapy in blood cancer, despite concerns about the powerful treatment’s side effects.

The group voted 11-0 that the benefits of Carvykti, a CAR-T medicine from Johnson & Johnson and Legend Biotech, outweighed its risk for patients with multiple myeloma whose disease has persisted despite initial treatment. The same panel voted 8-3 in favor of Abecma, from Bristol Myers Squibb and 2seventy Bio, for multiple myeloma patients who’ve received at least two lines of therapy. Currently both medicines are approved only for patients who have been treated for myeloma with four or more medications.

In clinical trials, each drug proved to significantly delay disease progression compared to standard therapy. But zooming in on the data, the FDA observed an alarming imbalance of deaths in the early months of both studies, finding that more patients in the CAR-T group died of myeloma or side effects than those receiving the standard of care.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Late stage cancers on the rise after pandemic delayed screenings

entertainment

WSS

How to ethically and practically extend health care to all

CDC recommends RSV monoclonal antibody for infants

Late stage cancers on the rise after pandemic delayed screenings

FDA authorizes Novavax’s updated Covid

A controversial new treatment promises to make little people taller

How I helped Pfizer think through the ethics of Viagra

hotspot

fashion

Wikipedia

What does generative AI mean for health care? We asked experts

Personalized medicine goes far beyond genetics

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Colorectal cancer study finds potential in overlooked immune cell

Tori Bowie and the unacceptable rates of Black maternal death

Study links childhood stress with decline in older age

After affirmative action ruling, medical educators look to 'holistic review'

Group behind ProMed defends move to subscription

DIEP, the 'gold standard' of breast reconstruction, is under threat

How to ethically and practically extend health care to all

Wikipedia

Phenylephrine and the overlooked value of the placebo effect

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Pharma showers House GOP doctor with campaign cash

The future of health care in the House

Liquid biopsy for lung cancer is launched by Delfi

H.R. 3 is the wrong path to lower drug costs

entertainment

explore

focus

Wikipedia